脑部放疗，上午比下午敏感许多！8 A* g2 t" m1 @5 v9 d0 F, i% S V% L
$ y9 q! N; G1 c+ q8 o- Z9 Z
" T3 F& R b$ y9 w* `- i5 zCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
2 Q) m+ s, {+ o- J2 H" r" mGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
4 _) G1 T" k3 l: o) mRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
" ^. ]4 Z0 K/ a Q4 A& f; {: ^- kSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
+ {% L' u" M1 `3 X4 m/ [7 Y* x/ K' ?9 Z( g/ T' \
Abstract
8 W/ n/ W" j* C: b5 r' u# `BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
/ u; T- R/ a% y5 ^7 O$ @
' Z( I' ~( V' ]( QMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic., k' e! Q2 U% r9 y/ M1 K) e4 P
- j, l/ {& L% Z& `' o @6 P
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
( L0 B& e( W q6 M5 O# o! X8 w0 }4 }0 ~6 D% l
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.% e) [$ e+ D4 S( g5 i
; z$ a/ Q; ^% W$ ]( b8 X3 J* i2 Y |
显身卡
